Pricing Log in Create free account

Celyad SA (CYAD) vs Seres Therapeutics, Inc. (MCRB)

Celyad SA and Seres Therapeutics, Inc. are both Biotechnology companies. Celyad SA and Seres Therapeutics, Inc. are of similar size ($25.2M and $23.8M). Celyad SA has the higher net margin (0.00% vs −1,192.9%) and the higher return on invested capital (0.00% vs −277.3%). Across the 13 metrics below, Celyad SA leads on 7 and Seres Therapeutics, Inc. on 6.

Valuation

Metric CYAD MCRB Biotechnology median
P/E n/m n/m 8.50
P/S n/m 12.68 9.71
P/B 11.18 0.69 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA — n/m 0.64
EV/Sales — 58.83 9.21
Earnings yield (708.87%) (98.78%) (33.15%)
Free cash flow yield (438.06%) (214.65%) (25.50%)

Profitability

Metric CYAD MCRB Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin — (4,462.77%) 0.00%
Net margin 0.00% (1,192.94%) 0.00%
Free cash flow margin 0.00% (2,721.83%) 0.00%
Return on equity 0.00% (66.57%) (56.36%)
Return on assets 0.00% (18.31%) (48.04%)
Return on invested capital 0.00% (277.30%) 0.00%

Growth

Metric CYAD MCRB Biotechnology median
Revenue growth (TTM) — (98.51%) 6.02%
EPS growth (last fiscal year) 113.33% 0.00% 30.26%
Revenue growth, 5-year CAGR (63.51%) (53.03%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CYAD MCRB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.94 2.11 4.72
Net debt to EBITDA (1.62) 0.51 0.96

Dividend

Metric CYAD MCRB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CYAD MCRB Biotechnology median
Market cap 23.79m 25.15m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack